Wells Fargo & Company Reneo Pharmaceuticals, Inc. Transaction History
Wells Fargo & Company
- $410 Billion
- Q1 2024
A detailed history of Wells Fargo & Company transactions in Reneo Pharmaceuticals, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 5,323 shares of RPHM stock, worth $7,824. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,323
Previous 4,818
10.48%
Holding current value
$7,824
Previous $7,000
14.29%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding RPHM
# of Institutions
69Shares Held
29.4MCall Options Held
125KPut Options Held
3.1K-
Nea Management Company, LLC Timonium, MD4.79MShares$7.03 Million0.56% of portfolio
-
Tang Capital Management LLC San Diego, CA3MShares$4.41 Million0.61% of portfolio
-
Highbridge Capital Management LLC New York, NY2.74MShares$4.02 Million1.03% of portfolio
-
Carlyle Group Inc. Washington, DC2.7MShares$3.97 Million0.33% of portfolio
-
River Vest Venture Management LLC St. Louis, MO2.53MShares$3.73 Million56.07% of portfolio
About Reneo Pharmaceuticals, Inc.
- Ticker RPHM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,479,600
- Market Cap $36M
- Description
- Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development of therapies for patients with rare genetic mitochondrial diseases. It develops REN001, a selective peroxisome proliferator-activated receptor delta agonist, which is in Phase IIb clinical trial in patients with primary mitochondrial myopathies, as w...